Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
9.31
-0.86 (-8.46%)
At close: Nov 20, 2026, 4:00 PM EST
9.25
-0.06 (-0.64%)
After-hours: Nov 20, 2026, 7:30 PM EST
Polyrizon Employees
As of December 31, 2025, Polyrizon had 4 total employees, including 2 full-time and 2 part-time employees. The number of employees decreased by 2 or 33.33% compared to the previous year. That makes Polyrizon the 42,381st largest employer in the world and 6,740th in the United States.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,145,500
Market Cap
22.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% | 2 | 2 |
| Dec 31, 2024 | 6 | - | - | 2 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 107 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| BriaCell Therapeutics | 31 |
| INmune Bio | 21 |
| Filana Therapeutics | 20 |
| ABVC BioPharma | 19 |
| Lite Strategy | 5 |
PLRZ News
- 11 days ago - Polyrizon adopts limited duration shareholder rights plan - TheFly
- 12 days ago - POLYRIZON ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN - GlobeNewsWire
- 26 days ago - Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker - GlobeNewsWire
- 6 weeks ago - Polyrizon files U.S. patent application for mucoadhesive technology - TheFly
- 6 weeks ago - Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform - GlobeNewsWire
- 2 months ago - Polyrizon enrolls first patient in U.S. study of NASARIX - TheFly
- 2 months ago - Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker - GlobeNewsWire
- 2 months ago - Polyrizon files to sell 404,166 ordinary shares for holders - TheFly